Abstract In 2009 the first European Society of Clinical Microbiology and Infection (ESCMID)
treatment guidance document for Clostridium difficile infection (CDI) was published. The …

Background Clostridium difficile infection (CDI) can lead to complications, recurrence, and
death. Numerous studies have assessed risk factors for these unfavourable outcomes, but …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Background The epidemiological landscape of Clostridium difficile infection (CDI) has
changed over the past 30 years. Aim To review studies of CDI in the community setting …

Objectives Clostridioides difficile infection (CDI), its subsequent recurrences (rCDIs), and
severe CDI (sCDI) provide a significant burden for both patients and the healthcare system …

The spore-forming gut bacterium Clostridium difficile is the leading cause of antibiotic-
associated diarrhea in hospitalized patients. The major virulence factors are two large …

Aim To determine the clinical utility of a rapid molecular assay for Clostridium difficile
infection (CDI) in an acute hospital setting. Methods From March to September 2011, stool …

Over the past two decades Clostridium difficile infection (CDI) has appeared as a major
public health threat. We performed a retrospective study based on the records of patients …

We evaluated incidence, case-fatality rate, and trends of community-associated (CA) and
healthcare-associated (HA) Clostridium difficile infections (CDIs) in Finland during 2008 …

BACKGROUND: Clostridium difficile infection (CDI) is significantly associated with
subsequent all-cause mortality. Although a number of studies have investigated mortality …